You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

phase 2 placebo multicenter double-blind placebo-controlled

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)

Recruiting
  • Chronic Spontaneous Urticaria
  • Oral EP262
  • Placebo
  • Birmingham, Alabama
  • +7 more
Oct 5, 2023

Atopic Dermatitis Trial (SAR444656 (KT-474), Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • SAR444656 (KT-474)
  • Placebo
  • (no location specified)
Sep 21, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp Trial (HY209GEL Active, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • +2 more
  • HY209GEL Active
  • Placebo
  • (no location specified)
Aug 31, 2023

Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • SGLT2 inhibitor
  • Seoul, Seodaemun-gu, Korea, Republic of
    Severance Hospital
Nov 17, 2023

Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)

Not yet recruiting
  • Achondroplasia
  • (no location specified)
Oct 6, 2023

Psoriasis Trial (SAR441566, Placebo)

Not yet recruiting
  • Psoriasis
  • (no location specified)
Oct 4, 2023

Type 2 Diabetes Trial in Beijing, Shijiazhuang (HEC88473, Placebo, Dulaglutide)

Recruiting
  • Type 2 Diabetes
  • HEC88473, Placebo, Dulaglutide
  • Beijing, Beijing, China
  • +1 more
Nov 20, 2023

Gout Trial (ABP-671, Allopurinol, Placebo)

Not yet recruiting
  • Gout
  • (no location specified)
Apr 5, 2023

Pain Trial (GSK3858279, Placebo)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 20, 2023

Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia Trial (OMN6, Placebo)

Not yet recruiting
  • Hospital-acquired Bacterial Pneumonia
  • Ventilator-associated Bacterial Pneumonia
  • (no location specified)
Oct 11, 2023

Heart Failure With Preserved Ejection Fraction Trial (CDR132L, Placebo)

Not yet recruiting
  • Heart Failure With Preserved Ejection Fraction
  • (no location specified)
Jul 18, 2023

Type 2 Diabetes Trial in Gwangju (JW0201, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus
  • Gwangju, Korea, Republic of
    Chosun University Hospital
Apr 3, 2023

Type 2 Diabetes Trial in Nanjing (, IBI362)

Recruiting
  • Type 2 Diabetes
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Jan 27, 2023

Lupus Nephritis Trial (Daxdilimab, Placebo (Normal Saline))

Not yet recruiting
  • Lupus Nephritis
  • (no location specified)
Sep 12, 2022

Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • ASC41 2 mg
  • +2 more
  • (no location specified)
Jan 30, 2023

Hypertension Trial (Placebo, lorundrostat Dose 1, lorundrostat Dose 2)

Not yet recruiting
  • Hypertension
  • Placebo
  • +2 more
  • (no location specified)
Nov 22, 2023

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Non-cystic Fibrosis Bronchiectasis (NCFBE) Trial in Guangzhou (HSK31858, )

Recruiting
  • Non-cystic Fibrosis Bronchiectasis (NCFBE)
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Guangzhou Medical University
Dec 6, 2022

Stress Urinary Incontinence Trial in Beijing (EG017 3mg, EG017 6mg)

Completed
  • Stress Urinary Incontinence
  • EG017 3mg
  • EG017 6mg
  • Beijing, Beijing, China
    People's Hospital of Peking University
Dec 30, 2022

NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Befotertinib + Icotinib placebo
  • Icotinib + Befotertinib placebo
  • Beijing, China
  • +2 more
Sep 20, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Tulsa, Waco (HTD1801, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Miami Lakes, Florida
  • +2 more
Jan 13, 2023

Crohn Disease Trial in Tyler (VTX958, VTX958 Placebo)

Recruiting
  • Crohn Disease
  • Tyler, Texas
    Local Site # 840101
Jan 17, 2023

Type 2 Diabetes Trial in Seoul (Treatment Period(JW0201), Treatment Period(Placebo), Extension Period(JW0201))

Recruiting
  • Type 2 Diabetes Mellitus
  • Treatment Period(JW0201)
  • +2 more
  • Seoul, Korea, Republic of
    Kangbuk Samsung Hospital
Apr 3, 2023

Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

Recruiting
  • Advanced Breast Cancer
  • Female Breast Cancer
  • FCN-437c,Fulvestrant,Goserelin acetate
  • Placebo,Fulvestrant,Goserelin acetate
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 30, 2022

Non-segmental Vitiligo Trial (MK-6194, Placebo)

Not yet recruiting
  • Non-segmental Vitiligo
  • MK-6194
  • Placebo
  • (no location specified)
Nov 6, 2023